TransDermal Technologies Inc. (TTI) has developed a patchless Transdermal
Delivery System (TDS®) that rapidly delivers molecules through the skin.
The TDS® is designed using TTI’s proprietary Molecular Evaluation System that
measures and calculates the intermolecular attractive and repulsive forces
of the drug of interest and the components of the TDS®. The TDS® formulation
process produces a dose-specific and drug-specific formula for rapid, safe
and efficient transdermal drug delivery.